Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hammer

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Human T-lymphotropic virus type III infection in previously immunocompromised hostsJ E Groopman, S M Hammer, S E Sallan, et al.
Transplantation|July 1, 1988
Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipientsM A Harbison, P C De Girolami, R L Jenkins, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 17, 1999
Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biasesI C Marschner, R A Betensky, V DeGruttola, et al.
AIDS (London, England)|November 1, 1995
HIV-1 Tat modulates invasion by a bacterial enteric pathogen into a human intestinal cell lineH B Mayer, C A Wanke, B Du, et al.
AIDS (London, England)|July 14, 2000
The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/lE P Coakley, M H Samore, J M Gillis, et al.
The American Review of Respiratory Disease|April 1, 1991
Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndromeR M Rose, A Krivine, P Pinkston, et al.
Journal of Virology|May 1, 1989
The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytesM A Albrecht, N A DeLuca, R A Byrn, et al.
Infection and Immunity|November 1, 1982
Herpes simplex virus infection of human T-cell subpopulationsS M Hammer, W P Carney, V R Iacoviello, et al.
Pharmacotherapy|January 1, 1987
Acyclovir-associated fever: a case reportB F Shea, M A Harbison, G P Sesin, et al.
AIDS Research and Human Retroviruses|May 3, 2000
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamS Kim, M D Hughes, S M Hammer, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Human T-lymphotropic virus type III infection in previously immunocompromised hostsJ E Groopman, S M Hammer, S E Sallan, et al.
Transplantation|July 1, 1988
Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipientsM A Harbison, P C De Girolami, R L Jenkins, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 17, 1999
Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biasesI C Marschner, R A Betensky, V DeGruttola, et al.
AIDS (London, England)|November 1, 1995
HIV-1 Tat modulates invasion by a bacterial enteric pathogen into a human intestinal cell lineH B Mayer, C A Wanke, B Du, et al.
AIDS (London, England)|July 14, 2000
The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/lE P Coakley, M H Samore, J M Gillis, et al.
The American Review of Respiratory Disease|April 1, 1991
Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndromeR M Rose, A Krivine, P Pinkston, et al.
Journal of Virology|May 1, 1989
The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytesM A Albrecht, N A DeLuca, R A Byrn, et al.
Infection and Immunity|November 1, 1982
Herpes simplex virus infection of human T-cell subpopulationsS M Hammer, W P Carney, V R Iacoviello, et al.
Pharmacotherapy|January 1, 1987
Acyclovir-associated fever: a case reportB F Shea, M A Harbison, G P Sesin, et al.
AIDS Research and Human Retroviruses|May 3, 2000
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamS Kim, M D Hughes, S M Hammer, et al.
Pageof 10